Page 4 - Affinity Technologies News Today

BioAffinity Technologies (NASDAQ:BIAF – Get Free Report) and OneMedNet (NASDAQ:ONMD – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk. Volatility & Risk bioAffinity Technologies has a beta […]

Indian Patent Office Grants Patent Related to Porphyrin Compounds for Targeted Cancer Treatment ...

SAN ANTONIO--(BUSINESS WIRE)-- #BIAF--Indian Patent Office issues patent to bioAffinity Technologies for porphyrin compounds related to targeted cancer treatment. ...

SAN ANTONIO--(BUSINESS WIRE)--Jan 8, 2024--

Here is a summary of the latest news about bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung...

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program. Compugen shares jumped 204.1% to $2.22 on Tuesday.

BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, today announced the appointment of Jamie...

SAN ANTONIO - bioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other lung diseases, today announced that the...

BIAF | Complete bioAffinity Technologies Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

BioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer and lung disease, today announced that David Elzi,...